Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.93% | $4.81M | €464.34B | 67.81% | 76 Outperform | |
| Roche Holding AG | 2.21% | $2.71M | CHF279.83B | 41.58% | 73 Outperform | |
| HSBC Holdings | 2.09% | $2.56M | £220.77B | 51.99% | 80 Outperform | |
| Novartis AG | 1.97% | $2.42M | CHF218.15B | 19.92% | 80 Outperform | |
| AstraZeneca | 1.93% | $2.37M | £210.86B | 19.89% | 80 Outperform | |
| Nestlé SA | 1.67% | $2.04M | CHF185.72B | 12.00% | 71 Outperform | |
| Siemens | 1.55% | $1.89M | €199.98B | 24.44% | 74 Outperform | |
| Shell (UK) | 1.53% | $1.88M | £158.23B | 4.31% | 73 Outperform | |
| SAP SE | 1.44% | $1.77M | €194.20B | -37.58% | 66 Neutral | |
| Banco Santander | 1.31% | $1.61M | €158.18B | 124.88% | 73 Outperform |